MP
Insider
Michael S Perry
DirectorMichael S Perry (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $1.0M of ARWR (11,600 sh × $87.30, as filed), executed Aug 18.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Aug 18
Filed Aug 20
Median ADV $181.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ARWRRecent filings
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
View filing →
$1.0M11,600 sh × $87.30
Exec Aug 18
Filed Aug 20 · 5:22 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. View filing → $992K
16,250 sh × $61.03
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET